SCHEMBL31364630

SCHEMBL31364630

Cn1ncc2c(C=O)cccc2c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 3/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ PABPC1 P11940 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ HPGD P15428 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ IMPDH2 P12268 1/20 0.38
▸ HIF1A Q16665 1/20 0.37
▸ TBXAS1 P24557 1/20 0.36
▸ PTGS1 P23219 3/20 0.36
▸ BRD4 O60885 2/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ IDO1 P14902 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31364625 0.85 HPGD (0.38) HTTMEN1KMT2AKDM4ELMNA
SCHEMBL12217744 0.79 ALDH1A1 (0.43) HTTMEN1KMT2AKDM4ELMNA
SCHEMBL23231062 0.77 BRD4 (0.43) HTTLMNAHPGDMAPK1TBXAS1
SCHEMBL31364631 0.76 HPGD (0.41) HTTKDM4ELMNAHPGDMAPK1
SCHEMBL16131514 0.76 HPGD (0.44) HTTKMT2AKDM4ELMNAHPGD
SCHEMBL23231094 0.76 HPGD (0.41) HTTMEN1KMT2AKDM4ELMNA
SCHEMBL331534 0.76 KEAP1 (0.44) HTTMEN1KMT2AKDM4ELMNA
SCHEMBL23231095 0.73 ALDH1A1 (0.54) HTTKMT2AKDM4ELMNASMN1; SMN2
SCHEMBL23899066 0.72 GAA (0.53) HTTMEN1KMT2AKDM4ELMNA
SCHEMBL31251323 0.72 GAA (0.53) HTTMEN1KMT2AKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025020886-A1 AZAQUINAZOLINE RING DERIVATIVE AND USE THEREOF 浙江星浩澎博医药有限公司 2025-01-30 — — WO disclosed
Send feedback